|
Originally published In Press as doi:10.1074/jbc.C200486200 on October 21, 2002
J. Biol. Chem., Vol. 277, Issue 50, 47972-47975, December 13, 2002
ACCELERATED PUBLICATION
Translocation of Small Preformed Vesicles Is Responsible for the
Insulin Activation of Glucose Transport in Adipose Cells
EVIDENCE FROM THE IN VITRO RECONSTITUTION
ASSAY*
Zhao
Xu and
Konstantin V.
Kandror
From the Boston University School of Medicine,
Boston, Massachusetts 02118
Received for publication, August 26, 2002, and in revised form, October 18, 2002
 |
ABSTRACT |
Insulin stimulates translocation of the glucose
transporter isoform 4 (Glut4) from an intracellular storage compartment
to the plasma membrane in fat and skeletal muscle cells. At present, the nature of the Glut4 storage compartment is unclear. According to
one model, this compartment represents a population of preformed small
vesicles that fuse with the plasma membrane in response to insulin
stimulation. Alternatively, Glut4 may be retained in large donor
membranes, and insulin stimulates the formation of transport vesicles
that deliver Glut4 to the cell surface. Finally, insulin can induce
plasma membrane fusion of the preformed vesicles and, also, stimulate
the formation of new vesicles. In extracts of fat and skeletal muscle
cells, Glut4 is predominantly found in small insulin-sensitive 60-70 S
membrane vesicles that may or may not artificially derive from large
donor membranes during cell homogenization. Here, we use a cell-free
reconstitution assay to demonstrate that small Glut4-containing
vesicles are formed from large rapidly sedimenting donor membranes in a
cytosol-, ATP-, time-, and temperature-dependent fashion
and, therefore, do not represent an artifact of homogenization. Thus,
small insulin-responsive vesicles represent the major form of Glut4
storage in the living adipose cell. Fusion of these vesicles with
the plasma membrane may be largely responsible for the primary effect
of insulin on glucose transport in fat tissue. In addition, our results
suggest that insulin may also stimulate the formation of Glut4 vesicles and accelerate Glut4 recycling to the plasma membrane.
 |
INTRODUCTION |
Insulin regulates postprandial blood glucose levels by reversible
translocation of the glucose transporter isoform 4 (Glut4)1 to the plasma
membrane in fat and skeletal muscle cells (1). The molecular mechanism
of this process is not completely understood. It is not known, in
particular, whether insulin stimulates plasma membrane fusion of the
pre-existing Glut4-containing vesicles, formation of new transport
vesicles from an intracellular storage compartment, or both.
Previously, we reported that, in extracts of adipose cells, the
majority of Glut4 is present in two distinct populations of small
membrane vesicles, one of which contains cellugyrin, whereas another
lacks this protein (2). Subsequent analysis suggested that
cellugyrin-positive vesicles transport Glut4 from early to recycling
endosomes, whereas cellugyrin-negative vesicles may represent a
specialized insulin-responsive population of vesicles that derive from
recycling endosomes (3). These data (see also Refs. 4-6) indicate that
insulin-responsive 60-70 S vesicles may represent the major form of
Glut4 storage in vivo. It is possible, however, that large
tubular membrane structures, such as endosomes, may be artificially
shattered during cell homogenization into rather homogeneous vesicular
population. Therefore, it is unclear whether the Glut4 storage
compartment in the living cell is represented by small vesicles or by
large fragile membrane structures. To address this question, we broke
rat adipocytes open without homogenization by centrifugation only. We
found that endosomes were not visibly affected by homogenization and
that the major pool of Glut4 was still compartmentalized in small
cellugyrin-positive and -negative vesicles, which, therefore, were not
likely to represent an artifact of homogenization (3).
We have now established a cell-free reconstitution assay for
cellugyrin-positive and -negative Glut4-containing vesicles, and we
show here that these vesicles can be formed in vitro in a
physiological process. This result supports our previous conclusion and
suggests that small 60-70 S insulin-responsive vesicles and not
large donor membranes represent the major form of Glut4 storage in the
living adipose cell. In addition, we found that insulin stimulated
formation of Glut4 vesicles in vitro by ~50%. Thus, although fusion of the preformed vesicles with the plasma membrane should mainly account for the initial effect of insulin on glucose transport in adipocytes, Glut4 recycling through intracellular compartments may also be expedited by insulin.
 |
EXPERIMENTAL PROCEDURES |
Materials--
In the present study we used monoclonal
anti-Glut4 antibody 1F8 (7) and rabbit polyclonal antibody against
cellugyrin (Ac-CQNVETTEGYQPPPVY-OH) that had been raised and
affinity-purified by BioSource International (Camarillo, CA).
Dexamethasone, 3-isobutyl-1-methylxanthine, insulin, benzamidine,
potassium aspartate, potassium glutamate, potassium gluconate, MOPS,
sodium carbonate, magnesium sulfate, glutathione (reduced form), ATP,
creatine phosphate, creatine phosphokinase, fetal bovine serum,
brefeldin A (BFA), wortmannin, guanosine 5'-( -thio)triphosphate (GTP S) and neomycin were purchased from Sigma. Aprotinin,
leupeptin, pepstatin A, and phenylmethylsulfonyl fluoride were
obtained from American Bioanalytical (Natick, MA). Calf bovine serum
and Dulbecco's modified Eagle's medium (DMEM) were purchased from Invitrogen.
Cell Culture--
Murine 3T3-L1 preadipocytes were cultured,
differentiated, and maintained as described previously (8). Briefly,
cells were grown in DMEM supplemented with 10% calf bovine serum until
confluence. Two days later, the cells were transferred to
differentiation medium (DMEM containing 10% fetal bovine serum, 0.5 mM 3-isobutyl-1-methylxanthine, 1 µM
dexamethasone, and 1.7 µM insulin). After 48 h, the
differentiation medium was replaced with maintenance medium (DMEM
supplemented with 10% fetal bovine serum). The maintenance medium was
changed every 48 h. The cells were used after 8 days of differentiation.
Preparation of Cytosol from Rat Brain and 3T3-L1
Adipocytes--
Brains were dissected from male Sprague-Dawley rats,
thoroughly washed with ice-cold budding buffer (9) (38 mM
potassium aspartate, 38 mM potassium glutamate, 38 mM potassium gluconate, 20 mM MOPS, 5 mM sodium carbonate, 2.5 mM magnesium sulfate,
5 mM reduced glutathione, 1 mM
phenylmethylsulfonyl fluoride, 1 µM pepstatin, 1 µM aprotinin, 1 µM leupeptin, pH 7.2), and
homogenized by 12 strokes with a Potter-Elvehjem Teflon pestle. The
homogenate was centrifuged at 16,000 × g for 20 min at
4 °C, and the supernatant was re-centrifuged at 200,000 × g for 1 h at 4 °C. The resulting supernatant (brain
cytosol) was aliquoted and stored at 80 °C. Cultured 3T3-L1
adipocytes were washed twice with ice-cold budding buffer and
homogenized by 10 strokes in a ball-bearing homogenizer (Isobiotec,
Heidelberg, Germany) with a 12-µm clearance. The cytosolic fraction was isolated from the homogenate according to the procedure described above and used fresh.
In Vitro Reconstitution of Glut4 Vesicles--
3T3-L1 adipocytes
were washed and homogenized as described in the previous section. The
homogenate was centrifuged at 16,000 × g for 20 min at
4 °C. The pellet (heavy membrane fraction) was washed twice with
ice-cold budding buffer and re-suspended in ice-cold budding buffer. In
some experiments, the pellet was washed with urea-containing stripping
buffer (2.5 M urea, 250 mM sorbitol, 20 mM HEPES, 5 mM magnesium acetate, 150 mM potassium acetate) prior to washes with budding buffer
(9). This procedure generally decreased the efficiency of Glut4 vesicle
budding but did not qualitatively change the results of the assay.
Washed heavy membrane fraction (250 µg per sample) was mixed with
cytosol and supplied with an ATP regeneration system (1 mM
ATP, 8 mM creatine phosphate, 1.5 unit/ml creatine
phosphokinase) in a total volume of 250 µl. Samples were kept on ice
for 5 min and transferred to 37 °C for the indicated periods of
time. Then, samples were centrifuged for the second time at 16,000 × g for 20 min at 4 °C. The pellets of the second
centrifugation (donor fraction) were removed, and supernatants were
centrifuged at 200,000 × g for 60 min in a Beckman Type 42.2 Ti rotor to harvest de novo formed small vesicles.
This vesicle fraction along with the donor fraction were analyzed by Western blotting.
Sucrose Gradient Centrifugation--
Samples (0.2 ml) were
loaded onto a 4.6-ml continuous 10-30% sucrose gradient and
centrifuged for 55 min in a Beckman SW-55 Ti rotor at 48,000 rpm. Each
gradient was collected into 25 fractions starting from the bottom of
the tube.
Gel Electrophoresis, Immunoblotting, and Protein
Content--
Proteins were separated in SDS-polyacrylamide gels
according to Laemmli (10), but without reducing agents, and were
transferred to an Immobilon-P membrane (Millipore) in 25 mM
Tris, 192 mM glycine. Following transfer, the membrane was
blocked with 10% non-fat dry milk in PBST (phosphate-buffered
saline with 0.5% Tween 20) for 1 h at 37 °C. Proteins were
visualized with specific antibodies, horseradish peroxidase-conjugated
secondary antibodies (Sigma), and an enhanced chemiluminescence
substrate kit (PerkinElmer Life Sciences). Protein content was
determined with the BCA kit (Pierce) according to manufacturer's instructions.
 |
RESULTS AND DISCUSSION |
3T3-L1 adipocytes were homogenized in a ball-bearing homogenizer,
and the homogenate was centrifuged at 16,000 × g for
20 min. Under these conditions, 27 ± 7% of the total Glut4 was
found in the heavy membrane fraction recovered in the pellet, whereas 73 ± 5% of Glut4 was present in the
supernatant.2
The heavy membrane fraction includes the plasma membrane (11),
endoplasmic reticulum (3, 11), mitochondria (11), Golgi membranes (11,
12), lysosomes,3 and
endosomes (3). Numerous studies (see, for example, Refs. 13 and 14)
including our own (15) demonstrate that, under basal conditions, there
is practically no Glut4 in the plasma membrane. In addition, it was
shown by several independent approaches that, upon homogenization of
rat adipocytes, the plasma membrane has the right-side-out orientation
and, therefore, cannot possibly serve as a donor compartment for the
formation of any type of vesicles (12, 16). Although these studies were
performed in primary rat adipocytes and not in 3T3-L1 cells, the plasma
membrane isolated from primary and cultured adipocytes may have the
same topology in vitro. The amount of Glut4 in the
endoplasmic reticulum is negligibly small in comparison with its total
pool (17). That leaves Golgi apparatus and endosomes as a possible
source of Glut4 in the heavy membrane fraction.
This fraction was washed as described under "Experimental
Procedures" and incubated at 4 °C or at 37 °C with and without
brain cytosol and ATP regeneration system in budding buffer for the indicated periods of time. Heavy membranes were then re-pelleted at
16,000 × g for 20 min (donor fraction), and de
novo formed vesicles were collected from the supernatant by
centrifugation at 200,000 × g for 60 min. Both donor
and vesicle fractions were analyzed by Western blotting (Fig.
1).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Formation of small Glut4 vesicles in
vitro is cytosol (A)-, ATP
(B)-, temperature (C)-, and time
(C)-dependent. 3T3-L1
adipocytes were incubated in serum-free DMEM overnight, homogenized in
a ball-bearing homogenizer, and centrifuged at 16,000 × g for 20 min. The pellet (250 µg) was incubated in the
absence and in the presence of rat brain cytosol (2 mg/ml unless
indicated otherwise) and an ATP regeneration system for 20 min (or for
indicated periods of time) at 4 °C or at 37 °C in a total volume
of 250 µl and centrifuged again in the same regime. The pellet of the
second centrifugation (Donor Fraction) was removed, and the
supernatant was centrifuged at 200,000 × g for 60 min
in a Beckman Type 42.2 Ti rotor. The pellet of the high speed
centrifugation (Vesicle Fraction) along with donor fraction
was analyzed by Western blot with 1F8 antibody and with polyclonal
antibody against cellugyrin. Each panel shows a representative result
of at least three independent experiments.
|
|
We found that both cellugyrin and Glut4 are re-distributed from heavy
membranes into the vesicle fraction in a cytosol-, ATP-, time-, and
temperature-dependent fashion (Fig. 1). It is seen in Fig.
1A that the amount of Glut4 re-distributed to the vesicle fraction is directly proportional to the concentration of brain cytosol, whereas the amount of cellugyrin in this fraction reaches its
maximum at 2 mg/ml cytosol and is not increased any further. Also, the yield of Glut4 in the vesicle fraction is decreased after 20 min of incubation, probably due to fusion of de novo formed
vesicles with other membranes present in the reaction mixture. On the
contrary, the yield of cellugyrin-containing vesicles steadily increases with time. This suggests that Glut4 and cellugyrin may be
localized in different types of vesicle formation, which may be
controlled by different molecular mechanisms.
In agreement with this hypothesis, the sedimentational analysis shows
that two types of vesicles are formed in vitro. These vesicles exactly correspond to cellugyrin-positive and
cellugyrin-negative vesicles present in cell extracts (Fig.
2). Together with our previous results
showing that these vesicles do not represent an artifact of cell
homogenization (3, 4), these data suggest that small Glut4 vesicles
exist in the living adipose cell and represent the major Glut4-storing
compartment in vivo. Such a conclusion is consistent with
results of immunoelectron microscopy, demonstrating that, in
adipocytes, Glut4 resides in small vesicles and short tubules with an
average diameter of 50-70 nm (13, 18).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 2.
The sedimentational distribution of small
vesicles formed in vitro and in vivo
is identical. In vitro formed vesicles (combined
from 18 individual assays described in the legend to Fig. 1) were
pooled, pelleted at 200,000 × g for 60 min,
re-suspended in phosphate-buffered saline, and fractionated in a
10-30% continuous sucrose gradient for 55 min at 48,000 rpm in a
Beckman SW-55 rotor at 4 °C. 16,000 × g supernatant
from 3T3-L1 adipocytes (0.55 mg) was fractionated in parallel. Each
gradient was separated into 25 fractions that were analyzed by Western
blotting with 1F8 antibody and with polyclonal antibody against
cellugyrin. The arrow indicates the direction of
sedimentation. A representative result of three independent experiments
is shown.
|
|
It is known that vesicle budding requires GTP binding to Arf (19), so
that this reaction is often stimulated in vitro by GTP S.
Indeed, we have determined that GTP S increases recruitment of the
adaptor complex AP1 onto donor membranes (results not shown). This,
however, does not significantly change the yield of small vesicles
(Fig. 3). We believe therefore that,
under our experimental conditions, GTP-bound Arf does not limit the
budding reaction. Also, addition of wortmannin does not significantly
affect the formation of Glut4- and cellugyrin-containing vesicles
in vitro (Fig. 3). BFA demonstrates some inhibitory activity
at concentrations that dramatically exceeds its ID50 and
even LD50 in vivo (20). Since BFA does not block
the formation of Glut4 vesicles in vivo (21), a small
inhibitory effect of BFA in vitro may not be specific. Aminoglycoside antibiotics neomycin (Fig. 3) and Geneticin (not shown)
significantly inhibit formation of vesicles, suggesting that
phospholipase D may be involved in regulation of vesicle budding (see
also Ref. 22). In our experiments, the inhibitory effect of
aminoglycosides in vitro does not exceed 50%. This may be
related to the fact that these compounds not only block vesicle budding, but also inhibit vesicle fusion with endosomes (23), thus
maintaining an equilibrium between small vesicles and donor membranes
in the reaction mixture.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Formation of small vesicles in
vitro in the presence of inhibitors. In
vitro budding assay was performed as described under
"Experimental Procedures" in the absence (Control) and
presence of wortmannin, GTP S, BFA, or neomycin taken at indicated
concentrations. In vitro formed vesicles were analyzed by
Western blot with 1F8 antibody (A) and with polyclonal
antibody against cellugyrin (B). The figure shows mean
values ± S.E. of three independent experiments (wortmannin,
GTP S) or a representative result of three independent experiments
(BFA, neomycin).
|
|
We believe that our data are, in general, consistent with recent
results of Lim et al. (9) who studied the formation of Glut4-containing vesicles in vitro using brain cytosol and
donor membranes from Myc-Glut4-transfected Chinese hamster ovary
cells. In both systems, formation of Glut4 vesicles is inhibited by
neomycin, whereas BFA does not have any major effect. Moreover, Lim
et al. (9) also found that the yield of Glut4 vesicles
formed de novo was decreased after the first 15 min of
incubation due to fusion with other membranes present in the reaction
mixture. A notable inconsistency in our results is that in their
experiments, GTP S powerfully inhibits vesicle budding. At present,
the reason for this discrepancy is not clear.
We have determined that adipocyte cytosol can support the formation of
small vesicles in vitro to the same extent as brain cytosol
that is routinely used in budding assays (Fig.
4). Thus, we decided to explore whether
or not insulin administration has any effect on the formation of small
vesicles in vitro. Since it is not known whether or not
insulin changes the amount of Glut4 and cellugyrin in donor membranes,
we figured that the direct comparison of vesicle formation in extracts
of insulin-treated and not treated cells would be difficult to
interpret. Therefore, we isolated the heavy membrane fraction and the
cytosol from basal and insulin-treated adipocytes, and we used these
fractions in the budding reaction in different combinations (Fig.
5). We found that insulin, indeed,
stimulated the formation of Glut4 vesicles in vitro by
~50%. A similar result was recently reported by Kristiansen and
Richter (24) who studied the formation of Glut4 vesicles in the
extracts of skeletal muscle cells. This increase, although rather
modest in in vitro experiments, may still be indicative of a
potentially larger effect in vivo, so that the stimulatory effect of insulin on vesicle budding in the living cell may be more
pronounced. This hypothesis is consistent with recent results of Foster
et al. (25) who showed, by immunofluorescence microscopy, that insulin accelerates inter-endosomal traffic of Glut4 in the L6
cell line. Thus, the results obtained in vitro with the help of the vesicle reconstitution assay suggest that fusion of small preformed Glut4 vesicles with the plasma membrane may account for the
initial stimulation of glucose transport by insulin in adipose cells.
In addition, insulin may stimulate the formation of Glut4 vesicles
de novo and thus increase the rate of Glut4 recycling
through its intracellular compartments to the plasma membrane.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Adipocyte cytosol supports the formation of
small vesicles in vitro. Reconstitution assay was
performed in vitro for the indicated periods of time as
described in the legend to Fig. 1 in the presence of adipocyte cytosol
(AC, 2 mg/ml), brain cytosol (BC, 2 mg/ml), or
budding buffer (BB) alone. In vitro formed
vesicles were analyzed by Western blot with 1F8 antibody and with
polyclonal antibody against cellugyrin.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of insulin on the formation of
small vesicles in vitro. Differentiated 3T3-L1
adipocytes were serum-starved overnight and treated or not treated with
insulin (100 nM) for 15 min. The heavy membrane fraction
(Donor membranes) and cytosol were prepared from
insulin-treated (+) and non-treated ( ) adipocytes as described under
"Experimental Procedures" and used in reconstitution assays in
different combinations. In vitro formed vesicles were
analyzed by Western blot with 1F8 antibody and with polyclonal antibody
against cellugyrin. A, Western blot of the vesicle fraction
obtained in a representative experiment. In the lanes marked
BB, cytosol was replaced with budding buffer. B,
normalized mean values ± S.E. of three independent experiments.
Cytosol from insulin-treated adipocytes significantly increased the
formation of small Glut4 vesicles from donor membranes isolated from
basal (p < 0.05) and from insulin-treated
(p < 0.01) cells. The effect of insulin on the
formation of cellugyrin-containing vesicles was not statistically
significant.
|
|
 |
FOOTNOTES |
*
This work was supported by research Grants DK52057 and
DK56736 from the National Institutes of Health and by a research grant from the American Diabetes Association (to K. V. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Boston University
School of Medicine, Dept. of Biochemistry, K124D, 715 Albany St.,
Boston, MA 02118. Tel.: 617-638-5049; Fax: 617-638-5339; E-mail:
kandror@biochem.bumc.bu.edu.
Published, JBC Papers in Press, October 21, 2002, DOI 10.1074/jbc.C200486200
2
M. Malikova and K. V. Kandror,
unpublished results.
3
K. V. Kandror, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
Glut4, glucose transporter isoform 4;
MOPS, 4-morpholinepropanesulfonic acid;
BFA, brefeldin A;
GTP S, guanosine 5'-( -thio)triphosphate;
DMEM, Dulbecco's modified Eagle's medium.
 |
REFERENCES |
| 1.
|
Bryant, N. J.,
Govers, R.,
and James, D. E.
(2002)
Nat. Rev. Mol. Cell. Biol.
3,
267-277[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Kupriyanova, T. A.,
and Kandror, K. V.
(2000)
J. Biol. Chem.
275,
36263-36268[Abstract/Free Full Text]
|
| 3.
|
Kupriyanova, T. A.,
Kandror, V.,
and Kandror, K. V.
(2002)
J. Biol. Chem.
277,
9133-9138[Abstract/Free Full Text]
|
| 4.
|
Kandror, K. V.,
Coderre, L.,
Pushkin, A. V.,
and Pilch, P. F.
(1995)
Biochem. J.
307,
383-390
|
| 5.
|
Heller-Harrison, R. A.,
Morin, M.,
Guilherme, A.,
and Czech, M. P.
(1996)
J. Biol. Chem.
271,
10200-10204[Abstract/Free Full Text]
|
| 6.
|
Bogan, J. S.,
McKee, A. E.,
and Lodish, H. F.
(2001)
Mol. Cell. Biol.
21,
4785-4806[Abstract/Free Full Text]
|
| 7.
|
James, D. E.,
Brown, R.,
Navarro, J.,
and Pilch, P. F.
(1988)
Nature
333,
183-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Stephens, J. M.,
Lee, J.,
and Pilch, P. F.
(1997)
J. Biol. Chem.
272,
971-976[Abstract/Free Full Text]
|
| 9.
|
Lim, S.-N.,
Bonzelius, F.,
Low, S. H.,
Wille, H.,
Weimbs, T.,
and Herman, G. A.
(2001)
Mol. Biol. Cell
12,
981-995[Abstract/Free Full Text]
|
| 10.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Simpson, I. A.,
Yver, D. R.,
Hissin, P. J.,
Wardzala, L. J.,
Karnieli, E.,
Salans, L. B.,
and Cushman, S. W.
(1983)
Biochim. Biophys. Acta
763,
393-407[Medline]
[Order article via Infotrieve]
|
| 12.
|
Hedo, J. A.,
and Simpson, I. A.
(1984)
J. Biol. Chem.
259,
11083-11089[Abstract/Free Full Text]
|
| 13.
|
Slot, S. W.,
Geuze, H. J.,
Gigengack, S.,
Lienhard, G. E.,
and James, D. E.
(1991)
J. Cell Biol.
113,
123-135[Abstract/Free Full Text]
|
| 14.
|
Malide, D.,
Ramm, G.,
Cushman, S. W.,
and Slot, J. W.
(2000)
J. Cell Sci.
113,
4203-4210[Abstract]
|
| 15.
|
Kandror, K. V.
(1999)
J. Biol. Chem.
274,
25210-25217[Abstract/Free Full Text]
|
| 16.
|
Jarett, L.,
and Smith, R. M.
(1974)
J. Biol. Chem.
249,
7024-7031[Abstract/Free Full Text]
|
| 17.
|
Roh, C.,
Roduit, R.,
Thorens, B.,
Fried, S.,
and Kandror, K. V.
(2001)
J. Biol. Chem.
276,
35990-35994[Abstract/Free Full Text]
|
| 18.
|
Smith, R. M.,
Charron, M. J.,
Shah, N.,
Lodish, H.,
and Jarett, L.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
6893-6897[Abstract/Free Full Text]
|
| 19.
|
Chavrier, P.,
and Goud, B.
(1999)
Curr. Opin. Cell Biol.
11,
466-475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Torii, S.,
Banno, T.,
Watanabe, T.,
Ikehara, Y.,
Murakami, K.,
and Nakayama, K.
(1995)
J. Biol. Chem.
270,
11574-11580[Abstract/Free Full Text]
|
| 21.
|
Martin, S.,
Ramm, G.,
Lyttle, C. T.,
Meerloo, T.,
Stoorvogel, W.,
and James, D. E.
(2000)
Traffic
1,
652-660[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Emoto, M.,
Klarlund, J. K.,
Waters, S. B., Hu, V.,
Buxton, J. M.,
Chawla, A.,
and Czech, M. P.
(2000)
J. Biol. Chem.
275,
7144-7151[Abstract/Free Full Text]
|
| 23.
|
Jones, A. T.,
and Wessling-Resnick, M.
(1998)
J. Biol. Chem.
273,
25301-25309[Abstract/Free Full Text]
|
| 24.
|
Kristiansen, S.,
and Richter, E. A.
(2002)
Am. J. Physiol.
283,
E374-E382[Abstract/Free Full Text]
|
| 25.
|
Foster, L. J., Li, D.,
Randhawa, V. K.,
and Klip, A.
(2001)
J. Biol. Chem.
276,
44212-44221[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Chakrabarti and K. V. Kandror
FoxO1 Controls Insulin-dependent Adipose Triglyceride Lipase (ATGL) Expression and Lipolysis in Adipocytes
J. Biol. Chem.,
May 15, 2009;
284(20):
13296 - 13300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shi, G. Huang, and K. V. Kandror
Self-assembly of Glut4 Storage Vesicles during Differentiation of 3T3-L1 Adipocytes
J. Biol. Chem.,
October 31, 2008;
283(44):
30311 - 30321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Randhawa, S. Ishikura, I. Talior-Volodarsky, A. W. P. Cheng, N. Patel, J. H. Hartwig, and A. Klip
GLUT4 Vesicle Recruitment and Fusion Are Differentially Regulated by Rac, AS160, and Rab8A in Muscle Cells
J. Biol. Chem.,
October 3, 2008;
283(40):
27208 - 27219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chakrabarti, T. Anno, B. D. Manning, Z. Luo, and K. V. Kandror
The Mammalian Target of Rapamycin Complex 1 Regulates Leptin Biosynthesis in Adipocytes at the Level of Translation: The Role of the 5'-Untranslated Region in the Expression of Leptin Messenger Ribonucleic Acid
Mol. Endocrinol.,
October 1, 2008;
22(10):
2260 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shisheva
Phosphoinositides in insulin action on GLUT4 dynamics: not just PtdIns(3,4,5)P3
Am J Physiol Endocrinol Metab,
September 1, 2008;
295(3):
E536 - E544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xu, S. Yu, C.-H. Hsu, J. Eguchi, and E. D. Rosen
The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis
PNAS,
February 19, 2008;
105(7):
2421 - 2426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Larance, G. Ramm, and D. E. James
The GLUT4 Code
Mol. Endocrinol.,
February 1, 2008;
22(2):
226 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shi and K. V. Kandror
The Luminal Vps10p Domain of Sortilin Plays the Predominant Role in Targeting to Insulin-responsive Glut4-containing Vesicles
J. Biol. Chem.,
March 23, 2007;
282(12):
9008 - 9016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Yu, J. Cresswell, M. G. Loffler, and J. S. Bogan
The Glucose Transporter 4-regulating Protein TUG Is Essential for Highly Insulin-responsive Glucose Uptake in 3T3-L1 Adipocytes
J. Biol. Chem.,
March 9, 2007;
282(10):
7710 - 7722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Eyster, Q. S. Duggins, G. J. Gorbsky, and A. L. Olson
Microtubule Network Is Required for Insulin Signaling through Activation of Akt/Protein Kinase B: EVIDENCE THAT INSULIN STIMULATES VESICLE DOCKING/FUSION BUT NOT INTRACELLULAR MOBILITY
J. Biol. Chem.,
December 22, 2006;
281(51):
39719 - 39727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xu, G. Huang, and K. V. Kandror
Phosphatidylinositol 4-Kinase Type II{alpha} Is Targeted Specifically to Cellugyrin-Positive Glucose Transporter 4 Vesicles
Mol. Endocrinol.,
November 1, 2006;
20(11):
2890 - 2897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gonzalez and T. E. McGraw
Insulin Signaling Diverges into Akt-dependent and -independent Signals to Regulate the Recruitment/Docking and the Fusion of GLUT4 Vesicles to the Plasma Membrane
Mol. Biol. Cell,
October 1, 2006;
17(10):
4484 - 4493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mari, P. Monzo, V. Kaddai, F. Keslair, T. Gonzalez, Y. Le Marchand-Brustel, and M. Cormont
The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes
J. Cell Sci.,
April 1, 2006;
119(7):
1297 - 1306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bose, A. Guilherme, S. Huang, A. C. Hubbard, C. R. Lane, N. A. Soriano, and M. P. Czech
The v-SNARE Vti1a Regulates Insulin-stimulated Glucose Transport and Acrp30 Secretion in 3T3-L1 Adipocytes
J. Biol. Chem.,
November 4, 2005;
280(44):
36946 - 36951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. Li and K. V. Kandror
Golgi-Localized, {gamma}-Ear-Containing, Arf-Binding Protein Adaptors Mediate Insulin-Responsive Trafficking of Glucose Transporter 4 in 3T3-L1 Adipocytes
Mol. Endocrinol.,
August 1, 2005;
19(8):
2145 - 2153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Malikova, J. Shi, and K. V. Kandror
V-type ATPase is involved in biogenesis of GLUT4 vesicles
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E547 - E552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Belfort and K. V. Kandror
Cellugyrin and Synaptogyrin Facilitate Targeting of Synaptophysin to a Ubiquitous Synaptic Vesicle-sized Compartment in PC12 Cells
J. Biol. Chem.,
November 28, 2003;
278(48):
47971 - 47978.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|